I actually only have one question, Mr. Chair, and we'll deal with that. I want to thank, first of all, our panel and our guests by video link who are joining us today.
I want to stick to the actual bill that's in front of us, and I'm going to ask Mr. Dearden a question and the same question to Mr. Abbott. Under the bill there is a change. At present, any drug leaving the country is approved by Health Canada. In the bill there is an option to have it approved by Health Canada or not, based on what the receiving country wants. I don't know the answer to this question: does that leave Canada with any legal liability because they're not exercising the opportunity to evaluate the drug before it leaves the country?
I'm assuming we have a liability now, since we've approved it. If we don't approve it, do we carry a new liability as a country? There are more than two legal minds here, but there are two people I've indicated to answer that question.